UNASSIGNED: In total, 129 patients whose treatment regimen started between January 2010 and October 2020 were included in this study. Patients were categorized into two groups based on the volume correction method used (lipofilling versus implant).
UNASSIGNED: In 35 (27%) patients (41 breasts), breast volume increasement was executed with an implant, while 94 (73%) patients (169 breasts) underwent volume increasement with lipofilling. The mean number of operations during the primary correction process was 1.2 (range 1-5) for the implant group and 2.4 (range 1-5) for the lipofilling group. When assessing the need for re-operations within 5 years after completing the primary correction, 46% of patients in the implant group needed further surgeries, while the corresponding proportion for the lipofilling group was 21% (p = 0.04). There were six major complications, all of them in the implant group.
UNASSIGNED: Implant-based reconstruction is associated with more revision surgeries and major complications compared to autologous lipofilling corrections. Lipofilling offers a more durable result with less re-operations over time despite initial sequential primary surgeries.
■总共,在2010年1月至2020年10月期间开始治疗方案的129名患者被纳入本研究。根据所使用的体积校正方法(脂肪填充与植入物)将患者分为两组。
■在35(27%)患者(41个乳房)中,用植入物增加乳房体积,而94(73%)患者(169例乳房)接受了脂肪填充的体积增加。在初次矫正过程中,植入物组为1.2(范围1-5),脂肪填充组为2.4(范围1-5)。在完成初步修正后5年内评估是否需要重新操作时,植入物组中有46%的患者需要进一步手术,而脂肪填充组的相应比例为21%(p=0.04)。有六种主要并发症,他们都在植入组。
■与自体脂肪填充矫正相比,基于植入物的重建与更多的翻修手术和主要并发症相关。尽管最初的顺序初级手术,但充脂术提供了更持久的结果,随着时间的推移,重复手术减少。